Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer

Details for Australian Patent Application No. 2004261779 (hide)

Owner The University of Sheffield

Inventors Helleday, Thomas

Agent Shelston IP

Pub. Number AU-B-2004261779

PCT Pub. Number WO2005/012524

Priority 0317466.1 25.07.03 GB

Filing date 23 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 24 July 2008

International Classifications

A61K 31/5517 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07D 487/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/012524 Priority application(s): WO2005/012524

24 July 2008 Application Accepted

  Published as AU-B-2004261779

20 November 2008 Standard Patent Sealed

22 January 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read: Use of RNAi inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261782-Expression systems for insect pest control

2004261765-Drilling method